People on the Move Archives - Page 99 of 126

Stylus Medicine Launches With $85M to Advance In Vivo Genetic Medicines and Next-Generation CAR-T Therapies

May 13, 2025

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

May 12, 2025

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

May 9, 2025

THIS WEEK'S STORIES

Novellia Wins 2025 MedTech Breakthrough Award for AI Innovation in Health Record Integration

May 8, 2025

TSOLife Raises $43 Million Series B to Advance AI-Driven Innovation in Senior Living Communities

May 7, 2025

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

May 12, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

People on the Move

Dr. Ellen Marmur Joins MedSpa Partners, Strengthening Northeast Presence and Industry Leadership

Ted Myles Named CEO of Cellarity as Company Prepares for First Clinical Trial

Adtalem Appoints Megan Noel as Chief Corporate Affairs Officer

Aera Therapeutics Names Paul Conrad as Chief Business and Financial Officer

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

Most Read

K Health’s AI Physician Mode Joins Mayo Clinic Platform to Boost Primary Care Efficiency

FDA Approves GE HealthCare’s Optison for Pediatric Use, Expanding Access to Enhanced Heart Imaging

Vicarious Surgical Partners with UMass Memorial Medical Center to Advance Robotic Surgery Integration

Freespira Gains FDA Clearance for At-Home Anxiety and PTSD Treatment for Adolescents

EDITOR PICKS

Stylus Medicine Launches With $85M to Advance In Vivo Genetic Medicines and Next-Generation CAR-T Therapies

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

THIS WEEK'S STORIES

Novellia Wins 2025 MedTech Breakthrough Award for AI Innovation in Health Record Integration

TSOLife Raises $43 Million Series B to Advance AI-Driven Innovation in Senior Living Communities

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

POPULAR CATEGORY

ABOUT US

FOLLOW US